Recent Updates
Recently added Catalysts
KURA Neutral Sentiment

PharmaVoice 100 Top Industry Leaders: Teresa Bair, J.D.

Key Takeaway: The article highlights Teresa Bair, J.D., as one of the top industry leaders in the PharmaVoice 100. It features her contributions and impact within the biopharma sector. The focus is on her leadership and achievements, showcasing her role in advancing the industry.
Price reaction · baseline $9.59 (2023-09-18 close) · hit pre-market · 1 other KURA headline(s) in the window, move may be shared
day 0 close · peak
+0.4%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+116%
120-day peak, hindsight
Typical move
5.7%
average across 9 past catalysts
Cash runway
~25 mo
Low dilution risk
Lead asset
Tipifarnib
Phase 2 · Leukemia, Myelomonocytic, Chronic

Frequently Asked Questions

Who is Teresa Bair?

Teresa Bair, J.D., is recognized as a top leader in the biopharma industry.

What is the PharmaVoice 100?

The PharmaVoice 100 is a list recognizing influential leaders in the pharmaceutical sector.

What contributions has Teresa Bair made?

Teresa Bair has made significant contributions to advancing the biopharma industry.

Last updated: Sep 19, 2023